Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pulmonx (LUNG) Shares Outstanding (Diluted Average) (2020 - 2025)

Pulmonx (LUNG) has disclosed Shares Outstanding (Diluted Average) for 6 consecutive years, with $40.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 2.97% to $40.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $40.4 million, a 2.97% increase, with the full-year FY2024 number at $39.1 million, up 2.99% from a year prior.
  • Shares Outstanding (Diluted Average) was $40.4 million for Q3 2025 at Pulmonx, up from $40.2 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $40.4 million in Q3 2025 to a low of $35.4 million in Q1 2021.
  • A 5-year average of $37.9 million and a median of $37.7 million in 2023 define the central range for Shares Outstanding (Diluted Average).
  • Peak YoY movement for Shares Outstanding (Diluted Average): soared 1776.17% in 2021, then rose 1.87% in 2023.
  • Pulmonx's Shares Outstanding (Diluted Average) stood at $36.1 million in 2021, then increased by 2.68% to $37.1 million in 2022, then grew by 2.37% to $38.0 million in 2023, then increased by 2.99% to $39.1 million in 2024, then rose by 3.41% to $40.4 million in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Shares Outstanding (Diluted Average) are $40.4 million (Q3 2025), $40.2 million (Q2 2025), and $40.0 million (Q1 2025).